John Yeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
John Yeh has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Jennifer Peresie
Department of Gynecology-Obstetrics, University at Buffalo, The State University of New York, Buffalo, New York
6 shared publicationsBeom Su Kim
Department of Gynecology-Obstetrics, University at Buffalo, The State University of New York, Buffalo, New York
4 shared publicationsJames A. Shelton
Department of Gynecology–Obstetrics, University at Buffalo, The State University of New York, Buffalo, NY, USA
4 shared publicationsBeomsu Kim
3 shared publicationsYuan Jing Liang
3 shared publicationsArmando Arroyo
2 shared publications
Latest Publications
- 7 July 2009
- Published by Springer Nature in Reproductive Sciences
- Vol. 16 (10) , 986-994
Declines in Levels of Hyperpolarization-Activated Cation (HCN) Channels in the Rat Ovary After Cisplatin Exposure
The distribution of the 4 hyperpolarization-activated cation (hyperpolarization-activated, cyclic nucleotide-gated [HCN]) channels (HCN1-4), channels associated with rhythmic electrical bursting, varies in the different cells of the ovary. Cisplatin is a broadly used chemotherapeutic agent that results in ovarian damage. The objective of this study was to test the hypothesis that cisplatin treatment will affect expression of the ovarian HCN channels. Adult female Sprague-Dawley rats were dosed with saline, 4.5 mg/kg cisplatin, or 6.0 mg/kg cisplatin as 2 weekly injections and then were killed 5 days after the second cisplatin dose. The ovaries were studied for HCN1-4 using semiquantitative H score immunohistochemical analysis and using Western blot analysis. By immunohistochemistry, for HCN4, the oocyte-specific staining declined after cisplatin treatment (P < .001). There was a decline in HCN2 intensity after cisplatin in the antral granulosa cells (P < .05) and thecal cells (P < .05). There were no differences found for the immunohistochemical HCN1 and HCN3 H scores after cisplatin. The Western blot analysis revealed that there was a decline in HCN3 levels after cisplatin exposure (P < .05). For HCN1 and HCN2, there was no change in the total ovarian protein levels after cisplatin. Treatment in vivo with cisplatin resulted in decline in the levels of the HCN channels in the rat ovary, with oocytes, antral cells, and thecal cells being specifically affected.
- 7 July 2009
- Published by Springer Nature in Reproductive Sciences
- Vol. 16 (10) , 986-994
Declines in Levels of Hyperpolarization-Activated Cation (HCN) Channels in the Rat Ovary After Cisplatin Exposure
The distribution of the 4 hyperpolarization-activated cation (hyperpolarization-activated, cyclic nucleotide-gated [HCN]) channels (HCN1-4), channels associated with rhythmic electrical bursting, varies in the different cells of the ovary. Cisplatin is a broadly used chemotherapeutic agent that results in ovarian damage. The objective of this study was to test the hypothesis that cisplatin treatment will affect expression of the ovarian HCN channels. Adult female Sprague-Dawley rats were dosed with saline, 4.5 mg/kg cisplatin, or 6.0 mg/kg cisplatin as 2 weekly injections and then were killed 5 days after the second cisplatin dose. The ovaries were studied for HCN1-4 using semiquantitative H score immunohistochemical analysis and using Western blot analysis. By immunohistochemistry, for HCN4, the oocyte-specific staining declined after cisplatin treatment (P < .001). There was a decline in HCN2 intensity after cisplatin in the antral granulosa cells (P < .05) and thecal cells (P < .05). There were no differences found for the immunohistochemical HCN1 and HCN3 H scores after cisplatin. The Western blot analysis revealed that there was a decline in HCN3 levels after cisplatin exposure (P < .05). For HCN1 and HCN2, there was no change in the total ovarian protein levels after cisplatin. Treatment in vivo with cisplatin resulted in decline in the levels of the HCN channels in the rat ovary, with oocytes, antral cells, and thecal cells being specifically affected.
- Open Access
- 14 April 2009
- Published by Hindawi Limited in Obstetrics and Gynecology International
- Vol. 2009, 1-11
The Potential Use of Intrauterine Insemination as a Basic Option for Infertility: A Review for Technology-Limited Medical Settings
Objective. There is an asymmetric allocation of technology and other resources for infertility services. Intrauterine insemination (IUI) is a process of placing washed spermatozoa transcervically into the uterine cavity for treatment of infertility. This is a review of literature for the potential use of IUI as a basic infertility treatment in technology-limited settings.Study design. Review of articles on treatment of infertility using IUI.Results. Aspects regarding the use of IUI are reviewed, including ovarian stimulation, semen parameters associated with good outcomes, methods of sperm preparation, timing of IUI, and number of inseminations. Implications of the finding in light of the needs of low-technology medical settings are summarized.Conclusion. The reviewed evidence suggests that IUI is less expensive, less invasive, and comparably effective for selected patients as a first-line treatment for couples with unexplained or male factor infertility. Those couples may be offered three to six IUI cycles in technology-limited settings.
- 14 April 2009
- Published by Hindawi Limited in Obstetrics and Gynecology International
- Vol. 2009, 1-11
Open AccessThe Potential Use of Intrauterine Insemination as a Basic Option for Infertility: A Review for Technology-Limited Medical Settings
Objective. There is an asymmetric allocation of technology and other resources for infertility services. Intrauterine insemination (IUI) is a process of placing washed spermatozoa transcervically into the uterine cavity for treatment of infertility. This is a review of literature for the potential use of IUI as a basic infertility treatment in technology-limited settings.Study design. Review of articles on treatment of infertility using IUI.Results. Aspects regarding the use of IUI are reviewed, including ovarian stimulation, semen parameters associated with good outcomes, methods of sperm preparation, timing of IUI, and number of inseminations. Implications of the finding in light of the needs of low-technology medical settings are summarized.Conclusion. The reviewed evidence suggests that IUI is less expensive, less invasive, and comparably effective for selected patients as a first-line treatment for couples with unexplained or male factor infertility. Those couples may be offered three to six IUI cycles in technology-limited settings.
- 1 October 2008
- Vol. 53 (10) , 785-8
Decreased maternal serum inhibin-A in pregestational diabetic women: implication for adjustment.
To evaluate the effect of maternal pregestational diabetes on serum dimeric inhibin-A (DIA), 1 of the 4 markers of the quadruple screen. The data were collected retrospectively from women with singleton pregnancies who had a quadruple screen drawn at 15-20 weeks of gestation in 2004-2006. A total of 84 women with pregestational diabetes were identified and their DIA values were compared with those of 100 nondiabetic pregnant women. We compared the mean multiples of the median (MoM) for DIA levels among diabetics, among nondiabetics and between the 2 types of diabetics. We also measured the degree of correlation between the quadruple screen markers and glycosylated hemoglobin (HbA1C). The corrected mean MoM for DIA levels among diabetic patients was 0.85 (95% CI, 0.77-0.95) vs. 1.0 (95% CI, 0.93-1.09) in the nondiabetic control group (p = 0.02). The mean MoMfor DIA levels did not appear to differ between type 1 and type 2 diabetes, and there does not appear to be a correlation between the quadruple screen markers and HbA1C. The DIA levels among pregestational diabetic women are lower than in the nondiabetic population, suggesting a need for adjustment.
- 1 October 2008
- Vol. 53 (10) , 785-8
Decreased maternal serum inhibin-A in pregestational diabetic women: implication for adjustment.
To evaluate the effect of maternal pregestational diabetes on serum dimeric inhibin-A (DIA), 1 of the 4 markers of the quadruple screen. The data were collected retrospectively from women with singleton pregnancies who had a quadruple screen drawn at 15-20 weeks of gestation in 2004-2006. A total of 84 women with pregestational diabetes were identified and their DIA values were compared with those of 100 nondiabetic pregnant women. We compared the mean multiples of the median (MoM) for DIA levels among diabetics, among nondiabetics and between the 2 types of diabetics. We also measured the degree of correlation between the quadruple screen markers and glycosylated hemoglobin (HbA1C). The corrected mean MoM for DIA levels among diabetic patients was 0.85 (95% CI, 0.77-0.95) vs. 1.0 (95% CI, 0.93-1.09) in the nondiabetic control group (p = 0.02). The mean MoMfor DIA levels did not appear to differ between type 1 and type 2 diabetes, and there does not appear to be a correlation between the quadruple screen markers and HbA1C. The DIA levels among pregestational diabetic women are lower than in the nondiabetic population, suggesting a need for adjustment.
- Open Access
- 18 August 2008
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 6 (1) , 35
The expression of hyperpolarization activated cyclic nucleotide gated (HCN) channels in the rat ovary are dependent on the type of cell and the reproductive age of the animal: a laboratory investigation
Aim of this study was to test the hypothesis that levels of hyperpolarization activated cyclic nucleotide gated channels 1 to 4 (HCN1-4) are linked to the reproductive age of the ovary.
- 18 August 2008
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 6 (1) , 35
Open AccessThe expression of hyperpolarization activated cyclic nucleotide gated (HCN) channels in the rat ovary are dependent on the type of cell and the reproductive age of the animal: a laboratory investigation
Aim of this study was to test the hypothesis that levels of hyperpolarization activated cyclic nucleotide gated channels 1 to 4 (HCN1-4) are linked to the reproductive age of the ovary.
- 31 May 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (5) , 1546-1556
Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging
- 31 May 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 89 (5) , 1546-1556
Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging
- 1 April 2008
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (4) , 463.e1-463.e7
Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats
- 1 April 2008
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (4) , 463.e1-463.e7
Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats
- 1 January 2008
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (1) , 82.e1-82.e6
Baseline and stimulated serum inhibin levels as biomarkers of cisplatin-induced ovarian damage in female rats
- 1 January 2008
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (1) , 82.e1-82.e6
Baseline and stimulated serum inhibin levels as biomarkers of cisplatin-induced ovarian damage in female rats
- Open Access
- 1 September 2007
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 86 (9) , 1051-1057
Association of pre‐pregnancy maternal body mass and maternal weight gain to newborn outcomes in twin pregnancies
Background. The rate of twin gestations is now about 3% of all pregnancies. The study objective was to investigate the association between twin pregnancy newborn outcomes and maternal weight. Methods. Birth certificate information of 1,342 sets of live‐born twin deliveries collected in a regional perinatal data system from a contiguous eight‐county area in upstate New York was studied. Results. The obese maternal pre‐pregnancy BMI category was correlated with an increased odds ratio of a “Type I” (both a ≥36‐week gestation and a ≥2,500‐g average twin weight) newborn outcome (adjusted OR 1.92; 95% CI: 1.43, 2.56). For total maternal weight gain, there was an increased odds ratio of having a Type I newborn outcome with >25 kg weight gain (adjusted OR 2.24; 95% CI: 1.51, 3.33). Conclusions. Based on this population‐based study, we conclude that both maternal pre‐pregnancy BMI and total maternal weight gain are associated with twin newborn outcomes.
- 1 September 2007
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 86 (9) , 1051-1057
Open AccessAssociation of pre‐pregnancy maternal body mass and maternal weight gain to newborn outcomes in twin pregnancies
Background. The rate of twin gestations is now about 3% of all pregnancies. The study objective was to investigate the association between twin pregnancy newborn outcomes and maternal weight. Methods. Birth certificate information of 1,342 sets of live‐born twin deliveries collected in a regional perinatal data system from a contiguous eight‐county area in upstate New York was studied. Results. The obese maternal pre‐pregnancy BMI category was correlated with an increased odds ratio of a “Type I” (both a ≥36‐week gestation and a ≥2,500‐g average twin weight) newborn outcome (adjusted OR 1.92; 95% CI: 1.43, 2.56). For total maternal weight gain, there was an increased odds ratio of having a Type I newborn outcome with >25 kg weight gain (adjusted OR 2.24; 95% CI: 1.51, 3.33). Conclusions. Based on this population‐based study, we conclude that both maternal pre‐pregnancy BMI and total maternal weight gain are associated with twin newborn outcomes.
- 1 May 2007
- Published by Elsevier in Fertility and Sterility
- Vol. 87 (5) , 1227-1230
Serum and ovarian Müllerian inhibiting substance, and their decline in reproductive aging
- 1 May 2007
- Published by Elsevier in Fertility and Sterility
- Vol. 87 (5) , 1227-1230
Serum and ovarian Müllerian inhibiting substance, and their decline in reproductive aging
- 1 January 2007
- Published by Springer Nature in Reproductive Sciences
- Vol. 14 (1) , 10-19
Increasing Blunting of Inhibin Responses to Dynamic Ovarian Challenge Is Associated With Reproductive Aging in the Rat
Reproductive aging results in declines in female fertility and in slight declines in baseline serum inhibins in humans. The authors tested the hypothesis that exogenous ovarian stimulation as a noninvasive dynamic test, by amplifying inhibin levels, can define more accurately than baseline serum inhibin levels the ovarian age of female rats. Female rats—young (immature, 26 days old), adult (65-75 days old), and reproductively aged (8- to 9-month-old retired breeders)—were administered pregnant mare's serum gonadotropin to stimulate the ovaries and the serum inhibin A and inhibin B, and ovarian inhibins were measured. The young and adult females had at least a 4- to 10-fold increase in serum inhibin A and inhibin B after ovarian stimulation, but the reproductively aged females did not. Adult female serum inhibin measurements after stimulation at every stage of the estrous cycle revealed a consistent 4- to 5-fold increase in all stages, whereas the reproductively aged females did not. Western blot analyses of ovarian lysates were consistent with the serum inhibin level results and revealed that ovarian inhibin α, inhibin β A, and inhibin β B subunit levels in adult ovaries were elevated after ovarian stimulation but not in the reproductively aged ovaries. The data presented here demonstrate that young, adult, and reproductively aged female inhibin responses after exogenous ovarian stimulation were different. Inhibin measurement in serum after ovarian challenge in rats, therefore, is a noninvasive method that could be used to dissect ovarian function in aging in more detail.
- 1 January 2007
- Published by Springer Nature in Reproductive Sciences
- Vol. 14 (1) , 10-19
Increasing Blunting of Inhibin Responses to Dynamic Ovarian Challenge Is Associated With Reproductive Aging in the Rat
Reproductive aging results in declines in female fertility and in slight declines in baseline serum inhibins in humans. The authors tested the hypothesis that exogenous ovarian stimulation as a noninvasive dynamic test, by amplifying inhibin levels, can define more accurately than baseline serum inhibin levels the ovarian age of female rats. Female rats—young (immature, 26 days old), adult (65-75 days old), and reproductively aged (8- to 9-month-old retired breeders)—were administered pregnant mare's serum gonadotropin to stimulate the ovaries and the serum inhibin A and inhibin B, and ovarian inhibins were measured. The young and adult females had at least a 4- to 10-fold increase in serum inhibin A and inhibin B after ovarian stimulation, but the reproductively aged females did not. Adult female serum inhibin measurements after stimulation at every stage of the estrous cycle revealed a consistent 4- to 5-fold increase in all stages, whereas the reproductively aged females did not. Western blot analyses of ovarian lysates were consistent with the serum inhibin level results and revealed that ovarian inhibin α, inhibin β A, and inhibin β B subunit levels in adult ovaries were elevated after ovarian stimulation but not in the reproductively aged ovaries. The data presented here demonstrate that young, adult, and reproductively aged female inhibin responses after exogenous ovarian stimulation were different. Inhibin measurement in serum after ovarian challenge in rats, therefore, is a noninvasive method that could be used to dissect ovarian function in aging in more detail.